Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Re-treatment for Patients With High-Risk Acute Myeloid Leukemia
Clinical trial NCT06643195 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06643195
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-01
- Primary completion
- 2027-09-30
- Enrollment
- 358
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.